CRMD
CorMedix Inc
NASDAQ: CRMD · HEALTHCARE · BIOTECHNOLOGY
$7.48
-1.19% today
Updated 2026-04-29
Market cap
$586.55M
P/E ratio
3.64
P/S ratio
1.88x
EPS (TTM)
$2.04
Dividend yield
—
52W range
$6 – $17
Volume
1.3M
CorMedix Inc (CRMD) Financial statements
SEC filings — annual and quarterly data.
Profit margin
52.30%
Operating margin
53.90%
ROE
66.60%
ROA
21.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | — | $-9.00M | — | — | — |
| 2009 | — | $-8.12M | — | — | — |
| 2010 | — | $-10.91M | — | — | — |
| 2011 | $0.00 | $-6.71M | — | — | — |
| 2012 | $0.00 | $-3.43M | — | — | — |
| 2013 | $2000.00 | $-9.13M | -9,980.20% | -245,769.75% | -456,654.90% |
| 2014 | $189274.00 | $-20.45M | -135.53% | -4,703.30% | -10,806.25% |
| 2015 | $210130.00 | $-18.19M | -51.68% | -7,925.56% | -8,655.37% |
| 2016 | $224105.00 | $-24.64M | -63.62% | -11,048.80% | -10,996.46% |
| 2017 | $329327.00 | $-33.01M | 65.09% | -9,997.39% | -10,023.45% |
| 2018 | $429797.00 | $-26.83M | 7.68% | -6,250.44% | -6,242.40% |
| 2019 | $283266.00 | $-16.43M | -31.76% | -7,416.31% | -5,801.29% |
| 2020 | $239231.00 | $-22.03M | 14.37% | -11,378.44% | -9,207.70% |
| 2021 | $190936.00 | $-28.21M | 22.00% | -15,417.51% | -14,774.70% |
| 2022 | $65408.00 | $-29.70M | 94.29% | -46,819.91% | -45,409.90% |
| 2023 | $0.00 | $-46.34M | — | — | — |
| 2024 | $43.47M | $-17.93M | 92.66% | -51.43% | -41.24% |
| 2025 | $311.71M | $163.06M | 88.46% | 48.17% | 52.31% |